<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK304142" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK304142/" /><meta name="ncbi_pagename" content="CHCHD10-Related Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>CHCHD10-Related Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="CHCHD10-Related Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/07/01" /><meta name="citation_author" content="Samira Ait-El-Mkadem" /><meta name="citation_author" content="Annabelle Chaussenot" /><meta name="citation_author" content="Sylvie Bannwarth" /><meta name="citation_author" content="Cécile Rouzier" /><meta name="citation_author" content="Véronique Paquis-Flucklinger" /><meta name="citation_pmid" content="26131548" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK304142/" /><meta name="citation_keywords" content="CHCHD10-Related Frontotemporal Dementia-Amyotrophic Lateral Sclerosis (FTD-ALS)" /><meta name="citation_keywords" content="Late-Onset Spinal Motor Neuronopathy (SMAJ)" /><meta name="citation_keywords" content="CHCHD10-Related Mitochondrial Myopathy" /><meta name="citation_keywords" content="CHCHD10-Related Amyotrophic Lateral Sclerosis (ALS)" /><meta name="citation_keywords" content="Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial" /><meta name="citation_keywords" content="CHCHD10" /><meta name="citation_keywords" content="CHCHD10-Related Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="CHCHD10-Related Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Samira Ait-El-Mkadem" /><meta name="DC.Contributor" content="Annabelle Chaussenot" /><meta name="DC.Contributor" content="Sylvie Bannwarth" /><meta name="DC.Contributor" content="Cécile Rouzier" /><meta name="DC.Contributor" content="Véronique Paquis-Flucklinger" /><meta name="DC.Date" content="2015/07/01" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK304142/" /><meta name="description" content="CHCHD10-related disorders are characterized by a spectrum of adult-onset neurologic findings that can include:" /><meta name="og:title" content="CHCHD10-Related Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="CHCHD10-related disorders are characterized by a spectrum of adult-onset neurologic findings that can include:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK304142/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/chchd10-dis/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK304142/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C4422E03F2E51000000000AA303C4.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK304142_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK304142_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/charge/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/chd2-dis/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK304142_"><span class="title" itemprop="name"><i>CHCHD10</i>-Related Disorders</span></h1><p class="contrib-group"><span itemprop="author">Samira Ait-El-Mkadem</span>, PhD, <span itemprop="author">Annabelle Chaussenot</span>, MD, <span itemprop="author">Sylvie Bannwarth</span>, PhD, <span itemprop="author">C&#x000e9;cile Rouzier</span>, MD, PhD, and <span itemprop="author">V&#x000e9;ronique Paquis-Flucklinger</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK304142_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK304142_ai__"><div class="contrib half_rhythm"><span itemprop="author">Samira Ait-El-Mkadem</span>, PhD<div class="affiliation small">Reference Center of Mitochondrial Disorders<br />Nice Hospital<br />Nice, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.ecin-uhc@s.idaas" class="oemail">rf.ecin-uhc@s.idaas</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Annabelle Chaussenot</span>, MD<div class="affiliation small">Reference Center of Mitochondrial Disorders<br />Nice Hospital<br />Nice, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.ecin-uhc@a.tonessuahc" class="oemail">rf.ecin-uhc@a.tonessuahc</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Sylvie Bannwarth</span>, PhD<div class="affiliation small">Reference Center of Mitochondrial Disorders<br />Nice Hospital<br />Nice, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.ecin-uhc@s.htrawnnab" class="oemail">rf.ecin-uhc@s.htrawnnab</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">C&#x000e9;cile Rouzier</span>, MD, PhD<div class="affiliation small">Reference Center of Mitochondrial Disorders<br />Nice Hospital<br />Nice, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.ecin-uhc@c.reizuor" class="oemail">rf.ecin-uhc@c.reizuor</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">V&#x000e9;ronique Paquis-Flucklinger</span>, MD, PhD<div class="affiliation small">Reference Center of Mitochondrial Disorders<br />Nice Hospital<br />Nice, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.ecinu@siuqap" class="oemail">rf.ecinu@siuqap</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">July 1, 2015</span>.</p><p><em>Estimated reading time: 24 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="chchd10-dis.Summary" itemprop="description"><h2 id="_chchd10-dis_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>CHCHD10</i>-related disorders are characterized by a spectrum of adult-onset neurologic findings that can include:</p><ul><li class="half_rhythm"><div>Mitochondrial myopathy (may also be early-onset): weakness, amyotrophy, exercise intolerance</div></li><li class="half_rhythm"><div>Amyotrophic lateral sclerosis (ALS): progressive degeneration of upper motor neurons (UMNs) and lower motor neurons (LMNs)</div></li><li class="half_rhythm"><div>Frontotemporal dementia (FTD): slowly progressive behavioral changes, language disturbances, cognitive decline, extrapyramidal signs</div></li><li class="half_rhythm"><div>Late-onset spinal motor neuronopathy (SMAJ): weakness, cramps, and/or fasciculations; areflexia</div></li><li class="half_rhythm"><div>Cerebellar ataxia: gait ataxia, kinetic ataxia (progressive loss of coordination of lower- and upper-limb movements), dysarthria/dysphagia, nystagmus, cerebellar oculomotor disorder</div></li></ul><p>Because of the recent discovery of <i>CHCHD10</i>-related disorders and the limited number of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported to date, the natural history of these disorders (except for SMAJ caused by the p.Gly66Val <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>) is largely unknown.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis is established when a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>CHCHD10</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is detected in an individual with one or more characteristic clinical findings.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Adequate nutrition and weight maintenance are essential. Appropriate bracing and stretching can minimize joint contractures, which are often painful and can interfere with caregiving. Those with weakness benefit from assistance with ambulation and posture. Management of ALS, FTD, SMA, and cerebellar ataxia is the same as for other causes of these disorders.</p><p><i>Surveillance:</i> Regular evaluations to detect manifestations that can occur with time including neurologic deficits, psychiatric abnormalities, impaired respiratory function, and sensorineural hearing loss.</p><p><i>Agents/circumstances to avoid:</i> Baclofen (used to treat spasticity) can sometimes worsen muscle weakness; some drugs used to treat the behavioral manifestations of FTD may worsen dysarthria, dysphagia, and/or respiratory weakness.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>CHCHD10</i>-related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Many individuals diagnosed with a <i>CHCHD10</i>-related disorder have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. The proportion of <i>CHCHD10</i>-related disorders caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is unknown. Each child of an individual with a <i>CHCHD10</i>-related disorder has a 50% chance of inheriting the <i>CHCHD10</i> pathogenic variant. Prenatal testing for pregnancies at increased risk is possible.</p></div></div><div id="chchd10-dis.GeneReview_Scope"><h2 id="_chchd10-dis_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="chchd10-dis.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK304142/table/chchd10-dis.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chchd10-dis.Td_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_chchd10-dis.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>CHCHD10</i>-Related Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_chchd10-dis.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Mitochondrial myopathy</div></li><li class="half_rhythm"><div>Amyotrophic lateral sclerosis (ALS)</div></li><li class="half_rhythm"><div>Frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS)</div></li><li class="half_rhythm"><div>Late-onset spinal motor neuronopathy (SMAJ)</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="chchd10-dis.TF.d.1"><p class="no_margin">For other genetic causes of these phenotypes, see <a href="#chchd10-dis.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="chchd10-dis.Diagnosis"><h2 id="_chchd10-dis_Diagnosis_">Diagnosis</h2><div id="chchd10-dis.Suggestive_Findings"><h3>Suggestive Findings</h3><p>A <i>CHCHD10</i>-related disorder <b>should be suspected</b> in an individual with <b>clinical findings</b> of a mitochondrial myopathy, amyotrophic lateral sclerosis, frontotemporal dementia, or late-onset spinal motor neuronopathy especially when the <b>family history</b> of these diverse phenotypes is consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance (including apparently <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> cases).</p><p>Note: Cerebellar ataxia may be present in combination with mitochondrial myopathy, ALS, and/or FTD.</p><div id="chchd10-dis.Clinical_Findings"><h4>Clinical Findings</h4><p><b>Mitochondrial myopathy</b></p><ul><li class="half_rhythm"><div>Signs of muscle weakness (proximal, axial, and/or facial, including ptosis), amyotrophy, or symptoms that suggest respiratory chain dysfunction, such as exercise intolerance</div></li></ul><p><b>Amyotrophic lateral sclerosis (ALS)</b></p><ul><li class="half_rhythm"><div>Characteristic signs and symptoms of progressive degeneration of upper motor neurons (UMNs) and lower motor neurons (LMNs)</div></li><li class="half_rhythm"><div>UMN manifestations include stiffness, spasticity, hyperreflexia, Babinski sign, and pseudobulbar palsy (dysphagia and dysarthria)</div></li><li class="half_rhythm"><div>LMN manifestations include weakness accompanied by muscle atrophy, fasciculations, areflexia, and cramping</div></li></ul><p>Note: Most individuals with <i>CHCHD10</i>-related ALS meet El Escorial criteria for ALS [<a class="bk_pop" href="#chchd10-dis.REF.brooks.2000.293">Brooks et al 2000</a>] and have both UMN and LMN involvement. (See also the <a href="/books/n/gene/als-overview/">Amyotrophic Lateral Sclerosis Overview</a>.)</p><p><b>Frontotemporal dementia (FTD)</b></p><ul><li class="half_rhythm"><div>Slowly progressive behavioral changes (disinhibition, loss of initiative, loss of interest in environment, psychiatric symptoms) [<a class="bk_pop" href="#chchd10-dis.REF.bird.1999.741">Bird et al 1999</a>, <a class="bk_pop" href="#chchd10-dis.REF.mioshi.2010.1591">Mioshi et al 2010</a>]</div></li><li class="half_rhythm"><div>Language disturbances (word-finding difficulties and semantic paraphasias, perseveration, and echolalia, mutism) [<a class="bk_pop" href="#chchd10-dis.REF.gornotempini.2011.1006">Gorno-Tempini et al 2011</a>]</div></li><li class="half_rhythm"><div>Cognitive decline (executive dysfunctions, attention disorders, and abstract reasoning inability)</div></li><li class="half_rhythm"><div>Extrapyramidal signs (rigidity, bradykinesia)</div></li></ul><p><b>Late-onset spinal motor neuronopathy (SMN) or spinal muscular atrophy, Jokela type (SMAJ)</b></p><ul><li class="half_rhythm"><div>LMN manifestations including: weakness, cramps, and/or fasciculations that are more proximal than distal; areflexia</div></li></ul><p><b>Cerebellar ataxia</b></p><ul><li class="half_rhythm"><div>Gait ataxia</div></li><li class="half_rhythm"><div>Kinetic ataxia (progressive loss of coordination of lower- and upper-limb movements)</div></li><li class="half_rhythm"><div>Dysarthria</div></li><li class="half_rhythm"><div>Dysphagia</div></li><li class="half_rhythm"><div>Nystagmus</div></li><li class="half_rhythm"><div>Cerebellar oculomotor disorder</div></li></ul></div><div id="chchd10-dis.Supportive_Laboratory_Findin"><h4>Supportive Laboratory Findings</h4><p>Although none of the following laboratory findings is specific, all could be considered supportive findings.</p><p><b>Neuroimaging</b></p><ul><li class="half_rhythm"><div>Frontal and/or temporal atrophy on brain CT or MRI [<a class="bk_pop" href="#chchd10-dis.REF.foster.1997.706">Foster et al 1997</a>, <a class="bk_pop" href="#chchd10-dis.REF.van_swieten.1999.617">van Swieten et al 1999</a>]</div></li><li class="half_rhythm"><div>Decrease of cerebral perfusion anteriorly (single-photon emission computed tomography [SPECT])</div></li><li class="half_rhythm"><div>Frontotemporal hypometabolism (positron emission tomography with <sup>18</sup>F-fluorodeoxyglucose [FDG-PET]) [<a class="bk_pop" href="#chchd10-dis.REF.foster.2007.2616">Foster et al 2007</a>]</div></li><li class="half_rhythm"><div>Reduced striatal uptake of <sup>18</sup>F-fluoro-L-dopa [<a class="bk_pop" href="#chchd10-dis.REF.wszolek.1992.312">Wszolek et al 1992</a>]</div></li></ul><p><b>Muscle biopsy</b> findings that support the diagnosis of a mitochondrial myopathy are ragged-red and/or COX negative fibers with or without multiple mtDNA deletions. Note that a muscle biopsy is not required for diagnosis of a <i>CHCHD10</i>-related disorder.</p><p><b>Electromyography and nerve conduction studies (EMG/NCS</b>) demonstrate widespread denervation due to LMN loss in the setting of relatively preserved sensory responses [<a class="bk_pop" href="#chchd10-dis.REF.gitcho.2008.535">Gitcho et al 2008</a>, <a class="bk_pop" href="#chchd10-dis.REF.k_hnlein.2008.1185">K&#x000fc;hnlein et al 2008</a>].</p><p><b>Serum CK concentration</b> is normal or high.</p></div></div><div id="chchd10-dis.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of a <i>CHCHD10</i>-related disorder <b>is established</b> when a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is detected in <i>CHCHD10</i> (<a class="figpopup" href="/books/NBK304142/table/chchd10-dis.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figchchd10disTmoleculargenetictesting" rid-ob="figobchchd10disTmoleculargenetictesting">Table 1</a>) in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with one or more of the above clinical findings.</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>CHCHD10</i> is most appropriate in individuals whose family history suggests a <i>CHCHD10-</i>related disorder and in individuals in whom other more common molecular causes of ALS / FTD-ALS / MND (motor neuron disease) have already been ruled out.To date no <i>CHCHD10</i> deletions/duplications have been reported.</div><div class="half_rhythm">Targeted analysis for the p.Gly66Val <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> can be performed first in individuals of Finnish ancestry with late-onset spinal motor neuronopathy (SMN) (SMAJ) [<a class="bk_pop" href="#chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>CHCHD10</i> and other genes of interest (see <a href="#chchd10-dis.Differential_Diagnosis">Differential Diagnosis</a>) can also be considered as the initial test. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>, and mitochondrial sequencing may be considered if single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>CHCHD10</i>) fails to confirm a diagnosis in an individual with features of a <i>CHCHD10</i>-related disorder. For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="chchd10-dis.T.molecular_genetic_testing" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>CHCHD10</i>-related Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK304142/table/chchd10-dis.T.molecular_genetic_testing/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chchd10-dis.T.molecular_genetic_testing_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_chchd10-dis.T.molecular_genetic_testing_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_chchd10-dis.T.molecular_genetic_testing_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_chchd10-dis.T.molecular_genetic_testing_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_chchd10-dis.T.molecular_genetic_testing_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHCHD10</i></td><td headers="hd_h_chchd10-dis.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup></td><td headers="hd_h_chchd10-dis.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">All pathogenic variants reported to date&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_chchd10-dis.T.molecular_genetic_testing_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>4</sup></td><td headers="hd_h_chchd10-dis.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported to date</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="chchd10-dis.TF.1.1"><p class="no_margin">See <a href="/books/NBK304142/#chchd10-dis.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#chchd10-dis.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>2. </dt><dd><div id="chchd10-dis.TF.1.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="chchd10-dis.TF.1.3"><p class="no_margin">Fewer than ten <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have been associated with a <i>CHCHD10-</i>related disorder. A <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> (<a class="figpopup" href="/books/NBK304142/table/chchd10-dis.T.chchd10_variants_discussed/?report=objectonly" target="object" rid-figpopup="figchchd10disTchchd10variantsdiscussed" rid-ob="figobchchd10disTchchd10variantsdiscussed">p.Gly66Val</a>) was identified in 55 individuals from 17 Finnish families [<a class="bk_pop" href="#chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</a>]. The <a class="figpopup" href="/books/NBK304142/table/chchd10-dis.T.chchd10_variants_discussed/?report=objectonly" target="object" rid-figpopup="figchchd10disTchchd10variantsdiscussed" rid-ob="figobchchd10disTchchd10variantsdiscussed">p.Arg15Leu</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was identified in six of 213 families with ALS [<a class="bk_pop" href="#chchd10-dis.REF.johnson.2014.e311">Johnson et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.m_ller.2014.e309">M&#x000fc;ller et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.kurzwelly.2015.e376">Kurzwelly et al 2015</a>]. Additional missense variants were identified in families [<a class="bk_pop" href="#chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.chaussenot.2014.2884.e1">Chaussenot et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.ajrouddriss.2015.1">Ajroud-Driss et al 2015</a>, <a class="bk_pop" href="#chchd10-dis.REF.dobsonstone.2015.e385">Dobson-Stone et al 2015</a>, <a class="bk_pop" href="#chchd10-dis.REF.zhang.2015.e380">Zhang et al 2015</a>] and <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (a single occurrence in a family) [<a class="bk_pop" href="#chchd10-dis.REF.chaussenot.2014.2884.e1">Chaussenot et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.ronchi.2015.e372">Ronchi et al 2015</a>, <a class="bk_pop" href="#chchd10-dis.REF.zhang.2015.e380">Zhang et al 2015</a>].</p></div></dd><dt>4. </dt><dd><div id="chchd10-dis.TF.1.4"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Included in the variety of methods that may be used are: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd></dl></div></div></div></div></div><div id="chchd10-dis.Clinical_Characteristics"><h2 id="_chchd10-dis_Clinical_Characteristics_">Clinical Characteristics</h2><div id="chchd10-dis.Clinical_Description"><h3>Clinical Description</h3><p>The phenotypic spectrum of <i>CHCHD10-</i>related disorders is broad and can include any of the following alone or in any combination: mitochondrial myopathy, amyotrophic lateral sclerosis, frontotemporal dementia, and late-onset spinal motor neuronopathy. Cerebellar ataxia may also be found in combination with these disorders, but not as the sole neurologic manifestation.</p><p><i>CHCHD10</i> pathogenic variants were originally identified in: (1) a large family with late-onset frontotemporal dementia (FTD), motor neuron disease (MND), cerebellar ataxia, and mitochondrial myopathy with mtDNA deletions [<a class="bk_pop" href="#chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</a>] and (2) a large family with early-onset mitochondrial myopathy without mtDNA deletions [<a class="bk_pop" href="#chchd10-dis.REF.ajrouddriss.2015.1">Ajroud-Driss et al 2015</a>].</p><p><i>CHCHD10</i> pathogenic variants have also been described in individuals with frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) and <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> and <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> pure ALS [<a class="bk_pop" href="#chchd10-dis.REF.chaussenot.2014.2884.e1">Chaussenot et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.johnson.2014.e311">Johnson et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.m_ller.2014.e309">M&#x000fc;ller et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.kurzwelly.2015.e376">Kurzwelly et al 2015</a>, <a class="bk_pop" href="#chchd10-dis.REF.ronchi.2015.e372">Ronchi et al 2015</a>, <a class="bk_pop" href="#chchd10-dis.REF.zhang.2015.e380">Zhang et al 2015</a>].</p><p>More recently, a <i>CHCHD10</i> <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> has been identified in 17 Finnish families with late-onset spinal motor neuronopathy (SMAJ) [<a class="bk_pop" href="#chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</a>].</p><p>Because of the recent discovery of <i>CHCHD10</i>-related disorders and the limited number of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported to date, the natural history of these disorders (except for late-onset spinal motor neuronopathy (SMAJ) caused by the p.Gly66Val <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>) is largely unknown.</p><p><b>Mitochondrial myopathy</b> may present with exercise intolerance; proximal, axial, and/or facial muscle weakness; ptosis; and amyotrophy. Deafness may also be observed.</p><ul><li class="half_rhythm"><div><b>Early-onset.</b> In a Puerto Rican family, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals had myopathy (appearing in the first decade of life) and short stature [<a class="bk_pop" href="#chchd10-dis.REF.ajrouddriss.2015.1">Ajroud-Driss et al 2015</a>].</div></li><li class="half_rhythm"><div><b>Late-onset.</b> In a French family, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals had late-onset myopathy with MND, FTD, and cerebellar ataxia [<a class="bk_pop" href="#chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</a>].</div></li></ul><p><b>Amyotrophic lateral sclerosis</b>
<b>(ALS).</b> The manifestations of ALS in <i>CHCHD10</i>-related disorders appear to overlap significantly with <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> and <i>SOD1</i>-related ALS (see <a href="/books/n/gene/als-overview/">ALS Overview</a>), including gender ratio, age of onset, symptom distribution, and severity of disease. Mean age of onset is 53 years (age range 25-75 years).</p><p>Although presentations of ALS of various etiologies may overlap, in <i>CHCHD10</i>-related ALS phenotypes the upper limbs seem to be more frequently involved at the onset and in <i>CHCHD10</i>-related FTD-ALS bulbar involvement is more predominant.</p><p>Bulbar dysfunction (atrophy of facial and masticatory muscles, perioral fasciculations, and severe dysphagia leading to frequent aspiration) become prominent in the final stages of the disease. Affected individuals eventually develop respiratory failure, which is the main cause of death.</p><p>Intra- and <a class="def" href="/books/n/gene/glossary/def-item/interfamilial-variability/">interfamilial variability</a> is observed even with the same <i>CHCHD10</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Mean disease duration prior to death is 8.6 years (range 2-17 years).</p><p>Note: <i>CHCHD10-</i>related ALS is clinically indistinguishable from ALS of other causes. However, based on published data, <i>CHCHD10-</i>related ALS may include upper-limb onset, flail-arm syndrome, and bulbar signs [<a class="bk_pop" href="#chchd10-dis.REF.m_ller.2014.e309">M&#x000fc;ller et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.bannwarth.2015.e377">Bannwarth et al 2015</a>, <a class="bk_pop" href="#chchd10-dis.REF.kurzwelly.2015.e376">Kurzwelly et al 2015</a>, <a class="bk_pop" href="#chchd10-dis.REF.ronchi.2015.e372">Ronchi et al 2015</a>]. Nevertheless, even within a family, clinical variability is considerable, especially regarding age of onset and longevity.</p><p><b>Frontotemporal dementia (FTD)</b> is a presenile dementia affecting the frontal and temporal cortex and some subcortical nuclei. Clinical presentation is variable. Affected individuals may have slowly progressive behavioral changes, language disturbance, and/or extrapyramidal signs. In individuals with <i>CHCHD10</i>-related FTD, symptoms started between ages 50 and 67 years. Disease duration was usually between four and 27 years. The disease progresses over a few years into profound dementia with mutism.</p><ul><li class="half_rhythm"><div><b>Behavioral changes.</b> Disinhibition and loss of initiative are the most common presenting symptoms. Affected individuals lose interest in their environment and neglect their personal hygiene. Obsessive-compulsive behavior and delusions or hallucinations are early clinical features in some. Roaming, restlessness, verbal aggressiveness, hyperorality (including alcohol abuse), and financial mismanagement are frequently seen [<a class="bk_pop" href="#chchd10-dis.REF.foster.1997.706">Foster et al 1997</a>, <a class="bk_pop" href="#chchd10-dis.REF.bird.1999.741">Bird et al 1999</a>].</div></li><li class="half_rhythm"><div><b>Psychiatric manifestations.</b> Persecutory delusions and visual or auditory hallucinations occur rarely in FTD and were not reported in individuals with mutation of <i>CHCHD10</i>.</div></li><li class="half_rhythm"><div><b>Cognitive decline.</b> Word-finding difficulties and semantic paraphasias in conversational speech are common early findings. Orientation in time and place, visuo-constructive functions, and short-term memory remain intact initially. Executive functions, attention, concentration, and abstract reasoning ability become impaired in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Language comprehension remains relatively preserved over the course of the disease. Perseveration, repetitive utterances, and echolalia lead to mutism after several years [<a class="bk_pop" href="#chchd10-dis.REF.foster.1997.706">Foster et al 1997</a>].</div></li><li class="half_rhythm"><div><b>Extrapyramidal signs.</b> Affected individuals may show parkinsonian signs including decreased facial expression, bradykinesia, postural instability, and rigidity without resting tremor. The extrapyramidal signs are unresponsive or only partially responsive to L-dopa treatment.</div></li></ul><p><b>Spinal motor neuronopathy</b> in <i>CHCHD10</i>-related disorders (SMAJ) is characterized by late onset. Affected individuals develop cramps and fasciculations, slowly progressive and predominantly lower-limb weakness, and diminished or absent deep tendon reflexes; respiratory symptoms are absent. Mild, non-progressive dysphagia appears later in the disease course in 13% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. About half of affected individuals develop mild reduction in sensory nerve amplitudes or reduced vibration sense in the distal lower limbs usually later in the disease course. Affected individuals remain ambulant for several decades after onset [<a class="bk_pop" href="#chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</a>].</p><p><b>Cerebellar ataxia</b> in <i>CHCHD10</i>-related disorders is characterized by ataxia, dysarthria, and eventual deterioration of bulbar functions. Onset is in the sixth decade. Affected individuals have difficulties in gait and slurred speech. They may first notice problems of balance in going down stairs or making sudden turns. In the early stages of disease <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may display brisk deep tendon reflexes, hypermetric saccades, and nystagmus [<a class="bk_pop" href="#chchd10-dis.REF.schmitzh_bsch.2006.1717">Schmitz-H&#x000fc;bsch et al 2006</a>]. Mild dysphagia, indicated by choking on food and drink, may also occur early in the disease.</p><p>As the disease progresses saccadic velocity slows and up-gaze palsy develops. Nystagmus often disappears with evolving saccadic abnormalities.</p><p>As the ataxia worsens, other cerebellar signs such as dysmetria, dysdiadochokinesia, and hypotonia become apparent.</p><p><b>Neuropathology.</b> To date no study of brain pathology has been performed in an individual with a <i>CHCHD10</i>-related disorder.</p></div><div id="chchd10-dis.GenotypePhenotype_Correlatio"><h3>Genotype-Phenotype Correlations</h3><p>No obvious <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation exists.</p><p>The clinical course of <i>CHCHD10</i>-related disorders is highly variable, even within a family, and is not predictable from the type or location of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p>The same <i>CHCHD10</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> can lead to different phenotypes; for example, individuals with the p.Ser59Leu pathogenic variant had different findings including ataxia and/or FTD and/or ALS; the only element common to all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from the large French family was the laboratory finding of a mitochondrial myopathy with numerous ragged-red and COX-negative fibers associated with multiple mtDNA deletions [<a class="bk_pop" href="#chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</a>]. No muscle biopsy was available from the affected individual with the same pathogenic variant reported by <a class="bk_pop" href="#chchd10-dis.REF.chaussenot.2014.2884.e1">Chaussenot et al [2014]</a>.</p><p>However, it should be noted that:</p><ul><li class="half_rhythm"><div>The <a class="figpopup" href="/books/NBK304142/table/chchd10-dis.T.chchd10_variants_discussed/?report=objectonly" target="object" rid-figpopup="figchchd10disTchchd10variantsdiscussed" rid-ob="figobchchd10disTchchd10variantsdiscussed">p.Arg15Leu</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> appears to predominate in <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> pure ALS [<a class="bk_pop" href="#chchd10-dis.REF.johnson.2014.e311">Johnson et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.m_ller.2014.e309">M&#x000fc;ller et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.kurzwelly.2015.e376">Kurzwelly et al 2015</a>].</div></li><li class="half_rhythm"><div>The p.Arg15Leu and <a class="figpopup" href="/books/NBK304142/table/chchd10-dis.T.chchd10_variants_discussed/?report=objectonly" target="object" rid-figpopup="figchchd10disTchchd10variantsdiscussed" rid-ob="figobchchd10disTchchd10variantsdiscussed">p.Pro80Leu</a> variants may be associated with fly-arm or predominant upper-limb involvement [<a class="bk_pop" href="#chchd10-dis.REF.m_ller.2014.e309">M&#x000fc;ller et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.kurzwelly.2015.e376">Kurzwelly et al 2015</a>, <a class="bk_pop" href="#chchd10-dis.REF.ronchi.2015.e372">Ronchi et al 2015</a>].</div></li><li class="half_rhythm"><div>The <a class="figpopup" href="/books/NBK304142/table/chchd10-dis.T.chchd10_variants_discussed/?report=objectonly" target="object" rid-figpopup="figchchd10disTchchd10variantsdiscussed" rid-ob="figobchchd10disTchchd10variantsdiscussed">p.Gly66Val</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was identified as a <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> in 17 Finnish families with SMAJ [<a class="bk_pop" href="#chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</a>]. Bulbar symptoms, mitochondrial myopathy, and cognitive dysfunction were exceptional findings in SMAJ even after decades of follow up, in contrast to individuals with the <a class="figpopup" href="/books/NBK304142/table/chchd10-dis.T.chchd10_variants_discussed/?report=objectonly" target="object" rid-figpopup="figchchd10disTchchd10variantsdiscussed" rid-ob="figobchchd10disTchchd10variantsdiscussed">p.Ser59Leu</a> pathogenic variant, for whom these were the most prominent clinical features [<a class="bk_pop" href="#chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.chaussenot.2014.2884.e1">Chaussenot et al 2014</a>].</div></li></ul></div><div id="chchd10-dis.Penetrance"><h3>Penetrance</h3><p>Penetrance is difficult to estimate because few unaffected individuals in families with a <i>CHCHD10</i>-related disorder have been genotyped or longitudinally followed for the emergence of symptoms.</p><p>Complete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> was described in all families with a <i>CHCHD10</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.ajrouddriss.2015.1">Ajroud-Driss et al 2015</a>, <a class="bk_pop" href="#chchd10-dis.REF.kurzwelly.2015.e376">Kurzwelly et al 2015</a>, <a class="bk_pop" href="#chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</a>] except two families with ALS and the <a class="figpopup" href="/books/NBK304142/table/chchd10-dis.T.chchd10_variants_discussed/?report=objectonly" target="object" rid-figpopup="figchchd10disTchchd10variantsdiscussed" rid-ob="figobchchd10disTchchd10variantsdiscussed">p.Arg15Leu</a> variant [<a class="bk_pop" href="#chchd10-dis.REF.m_ller.2014.e309">M&#x000fc;ller et al 2014</a>] and one with the p.Pro34Ser variant [<a class="bk_pop" href="#chchd10-dis.REF.dobsonstone.2015.e385">Dobson-Stone et al 2015</a>]. More reports will be needed before the penetrance can be more accurately established.</p></div><div id="chchd10-dis.Prevalence"><h3>Prevalence</h3><p>The prevalence of <i>CHCHD10</i>-related disorders is not known at present. However, based on the first published series, prevalence of <i>CHCHD10-</i>related disorders is estimated at 1.4%-3.5% in individuals of European ancestry with ALS or the FTD-ALS spectrum [<a class="bk_pop" href="#chchd10-dis.REF.dobsonstone.2015.e385">Dobson-Stone et al 2015</a>].</p><p>Mutation of <i>CHCHD10</i> appears to rank immediately following mutation of <i>C9ORF72</i> and <i>SOD1</i> as a cause of <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> ALS [<a class="bk_pop" href="#chchd10-dis.REF.renton.2011.257">Renton et al 2011</a>].</p><p><i>CHCHD10 p</i>athogenic variants have been identified in individuals from different geographic regions, including America and Europe.</p></div></div><div id="chchd10-dis.Genetically_Related_Allelic"><h2 id="_chchd10-dis_Genetically_Related_Allelic_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with mutation of <i>CHCHD10.</i></p></div><div id="chchd10-dis.Differential_Diagnosis"><h2 id="_chchd10-dis_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Mitochondrial myopathy.</b> For a detailed discussion and the differential diagnosis of mitochondrial myopathy, see <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a>.</p><p><b>Sporadic and <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> ALS.</b> For a detailed discussion of these disorders and the differential diagnosis of ALS, see <a href="/books/n/gene/als-overview/">Amyotrophic Lateral Sclerosis Overview</a>.</p><p><b>Familial ALS (FALS)</b> (i.e., presence of at least two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members)</p><ul><li class="half_rhythm"><div>Because approximately 20% of FALS is caused by mutation of <i>SOD1</i> and approximately 30% by mutation of <i>C9ORF72</i>, a tiered approach to testing a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> FALS should begin with <i>C9ORF72</i>
<b>and</b>
<i>SOD1</i> sequencing.</div></li><li class="half_rhythm"><div>If neither a <i>C9ORF72</i> nor a <i>SOD1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified, sequencing of <i>CHCHD10</i> should be performed. Based on published data available to date, variants in <i>CHCHD10</i> appear to be the third most common cause of FALS [<a class="bk_pop" href="#chchd10-dis.REF.johnson.2014.e311">Johnson et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.m_ller.2014.e309">M&#x000fc;ller et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.kurzwelly.2015.e376">Kurzwelly et al 2015</a>, <a class="bk_pop" href="#chchd10-dis.REF.zhang.2015.e380">Zhang et al 2015</a>].</div></li><li class="half_rhythm"><div>Although in some instances testing for other rare genetic causes of FALS can be considered, these disorders have a distinctive clinical presentation or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance pattern (see <a href="/books/n/gene/als-overview/">Amyotrophic Lateral Sclerosis Overview</a>).</div></li></ul><p><b>Sporadic ALS (SALS)</b> (i.e., single occurrence in a family). Sequencing of <i>CHCHD10</i> in SALS can be performed.</p><ul><li class="half_rhythm"><div><a class="bk_pop" href="#chchd10-dis.REF.ronchi.2015.e372">Ronchi et al [2015]</a> also identified the <i>CHCHD10</i> variants p.Pro34Ser (2 patients) and p.Pro80Leu (1 patient) in Italians with <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> ALS/FTD-ALS corresponding to 1.4% of Italians with a diagnosis of probable or definite motor neuron disease.</div></li><li class="half_rhythm"><div>In the data sets of <a class="bk_pop" href="#chchd10-dis.REF.zhang.2015.e380">Zhang et al [2015]</a> the estimated mutation frequency is 1.2% for <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> ALS.</div></li></ul><p><b>Sporadic or <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> FTD-ALS</b> (i.e., presence of at least two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members)</p><ul><li class="half_rhythm"><div>Because FTD/ALS is mainly caused by mutation of <i>C9ORF72</i>, <i>MAPT</i>, <i>FUS1</i>, <i>GRN</i>, <i>TARDBP</i>, and <i>VCP</i>, a tiered approach to testing a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> FTD-ALS should begin with sequencing of these genes.</div></li><li class="half_rhythm"><div>If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified in <i>C9ORF72</i>, <i>MAPT</i>, <i>FUS1</i>, <i>GRN</i>, <i>TARDBP</i>, or <i>VCP</i>, sequencing of <i>CHCHD10</i> should then be performed.</div></li></ul><p><i>CHCHD10</i>-associated ALS must be differentiated from mimics of ALS. Detailed clinical evaluation (as outlined above) usually allows the exclusion of other disorders. The rate of misdiagnosis in ALS is highest in individuals presenting with purely lower motor neuron findings [<a class="bk_pop" href="#chchd10-dis.REF.traynor.2000.109">Traynor et al 2000</a>].</p><p>Disorders of any cause that mimic ALS are numerous and include:</p><ul><li class="half_rhythm"><div>Multifocal motor neuropathy</div></li><li class="half_rhythm"><div>Cervical spondylosis</div></li><li class="half_rhythm"><div>Adult-onset <a href="/books/n/gene/sma/">spinal muscular atrophy</a> (SMA)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/kennedy/">Kennedy disease</a> (<a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> spinobulbar muscular atrophy [SBMA])</div></li><li class="half_rhythm"><div>Acquired and hereditary motor neuropathies (see <a href="/books/n/gene/cmt/">Charcot-Marie-Tooth Hereditary Neuropathy Overview</a>)</div></li><li class="half_rhythm"><div>Late-onset GM2 gangliosidosis (see <a href="/books/n/gene/tay-sachs/">Hexosaminidase A Deficiency</a>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/apbd/">Adult polyglucosan body disease</a></div></li></ul><p>See <a class="figpopup" href="/books/NBK304142/table/chchd10-dis.T.other_genes_associated_wit/?report=objectonly" target="object" rid-figpopup="figchchd10disTothergenesassociatedwit" rid-ob="figobchchd10disTothergenesassociatedwit">Table 2</a> for a list of other genes associated with FALS.</p><div id="chchd10-dis.T.other_genes_associated_wit" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Other Genes Associated with FALS</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK304142/table/chchd10-dis.T.other_genes_associated_wit/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chchd10-dis.T.other_genes_associated_wit_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Selected <i>GeneReview</i></th><th id="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Protein</th><th id="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Selected OMIM</th></tr></thead><tbody><tr><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ANG</i></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/als-overview/">ALS Overview</a></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Angiogenin</td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/611895" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">611895</a></td></tr><tr><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DCTN1</i></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/als-overview/">ALS Overview</a></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dynactin</td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/105400" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">105400</a></td></tr><tr><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FUS/TLS</i></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/als-overview/">ALS Overview</a></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fused in sarcoma/translated in liposarcoma</td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/608030" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">608030</a></td></tr><tr><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SETX</i></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/als-overview/">ALS Overview</a></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Senataxin</td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/602433" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">602433</a></td></tr><tr><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SOD1</i></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/als-overview/">ALS Overview</a></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Superoxide dismutase [Cu-Zn]</td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/105400" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">105400</a></td></tr><tr><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TARDBP</i></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/tardbp-als/"><i>TARDBP</i>-Related ALS</a></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">TAR DNA-binding protein 43</td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/612069" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">612069</a></td></tr><tr><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>VAPB</i></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/als-overview/">ALS Overview</a></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vesicle-associated membrane protein-associated protein B/C</td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/608627" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">608627</a></td></tr><tr><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>VCP</i></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ibmpfd/">Inclusion Body Myopathy w/Paget Disease of Bone and/or FTD</a></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Transitional endoplasmic reticulum ATPase</td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/613954" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613954</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Pathogenic variants in many of these genes have also been identified in small numbers of <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases of ALS (i.e., a single occurrence of ALS in a family).</p></div></dd></dl></div></div></div><p><b>FTD-ALS.</b> Structural imaging may show focal atrophy and may exclude other causes of dementia (e.g., frontal meningioma, chronic subdural hematoma).</p><p>The disorders of any cause that mimic FTD include:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/alzheimer/">Alzheimer disease</a> when individuals present with mild behavioral changes, prominent memory disturbance and loss of initiative, or word-finding problems in the absence of evident frontotemporal atrophy on neuroimaging.</div></li><li class="half_rhythm"><div>Familial Parkinson disease when parkinsonism is present (see <a href="/books/n/gene/parkinson-overview/">Parkinson Disease Overview</a>). Other <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neurologic diseases associated with dementia or parkinsonian features including <a href="/books/n/gene/huntington/">Huntington disease</a>, dementia with Lewy bodies, and <a href="/books/n/gene/prion/">prion diseases</a> also need to be considered.</div></li></ul><p>Non-genetic acquired causes of dementia should always be considered.</p><p>About 25% of persons with FTD have a positive family history and demonstrate an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> pattern of inheritance.</p><p>See <a class="figpopup" href="/books/NBK304142/table/chchd10-dis.T.other_genes_associated_wit_1/?report=objectonly" target="object" rid-figpopup="figchchd10disTothergenesassociatedwit1" rid-ob="figobchchd10disTothergenesassociatedwit1">Table 3</a> for a list of other genes associated with FTD-ALS.</p><div id="chchd10-dis.T.other_genes_associated_wit_1" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Other Genes Associated with FTD-ALS</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK304142/table/chchd10-dis.T.other_genes_associated_wit_1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chchd10-dis.T.other_genes_associated_wit_1_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Selected <i>GeneReview</i></th><th id="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Protein</th><th id="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Selected OMIM</th></tr></thead><tbody><tr><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>C9orf72</i></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/als-ftd/"><i>C9orf72</i>-Related ALS &#x00026; FTD</a></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Uncharacterized protein C9orf72</td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/105550" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">105550</a></td></tr><tr><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHMP2B</i></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ftd-chmp2b/">FTD, Chromosome 3-Linked</a></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Charged multivesicular body protein 2b</td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/600795" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">600795</a></td></tr><tr><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GRN (PGRN)</i></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ftd-grn/"><i>GRN</i>-Related FTD</a></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Granulins</td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/607485" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">607485</a></td></tr><tr><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MAPT</i></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Microtubule-associated protein tau</td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/600274" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">600274</a></td></tr><tr><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TARDBP</i></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/tardbp-als/"><i>TARDBP</i>-Related ALS</a></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">TAR DNA-binding protein 43</td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/612069" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">612069</a></td></tr><tr><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>VCP</i></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ibmpfd/">Inclusion Body Myopathy w/Paget Disease of Bone and/or FTD</a></td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Valosin-containing protein</td><td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/167320" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">167320</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Pathogenic variants in many of these genes have also been identified in small numbers of <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases of ALS (i.e., a single occurrence in a family).</p></div></dd><dt></dt><dd><div><p class="no_margin">ALS = amyotrophic lateral sclerosis; FTD = frontotemporal dementia</p></div></dd></dl></div></div></div><p><b>Cerebellar ataxia.</b> For a detailed discussion and the differential diagnosis of inherited ataxias myopathy, see <a href="/books/n/gene/ataxias/">Hereditary Ataxia Overview</a>.</p></div><div id="chchd10-dis.Management"><h2 id="_chchd10-dis_Management_">Management</h2><div id="chchd10-dis.Evaluations_Following_Initia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an individual diagnosed with a <i>CHCHD10</i>-related disorder, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>A structured general medical history and family history</div></li><li class="half_rhythm"><div>Physical examination and neurologic examination</div></li><li class="half_rhythm"><div>EMG/NCS to document the regions of involvement and indicate lower motor neuron and/or myopathic involvement</div></li><li class="half_rhythm"><div>Evaluation of the extent and profile of cognitive disturbance by neuropsychological examination</div></li><li class="half_rhythm"><div>Neuroimaging with MRI if not done at time of initial diagnosis.</div></li><li class="half_rhythm"><div>Pulmonary function testing to detect and stage respiratory involvement</div></li><li class="half_rhythm"><div>Speech and swallowing evaluation if dysarthria and/or dysphagia are present to direct care to minimize risk of aspiration and to initiate augmentative communication strategies for possible loss of verbal communication</div></li><li class="half_rhythm"><div>Audiologic examination, including auditory brain stem responses (ABRs) and evoked otoacoustic emissions</div></li><li class="half_rhythm"><div>Physical and occupational therapy evaluation to determine the adaptive devices needed to maximize function</div></li><li class="half_rhythm"><div>Nutritional evaluation</div></li><li class="half_rhythm"><div>Screening to detect depression and assess need for psychosocial support</div></li><li class="half_rhythm"><div>Clinical genetics consultation</div></li></ul></div><div id="chchd10-dis.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>General</b></p><ul><li class="half_rhythm"><div>Adequate nutrition and weight maintenance are essential. Percutaneous gastrostomy is often appropriate to maintain adequate caloric intake in persons with significant bulbar involvement.</div></li><li class="half_rhythm"><div>Joint contractures can occur, are often painful, and can interfere with caregiving. Appropriate bracing and stretching can minimize contractures.</div></li></ul><p><b>Mitochondrial myopathy</b></p><ul><li class="half_rhythm"><div>Assistance with ambulation and posture</div></li><li class="half_rhythm"><div>Surgical correction of ptosis as needed</div></li></ul><p><b>Amyotrophic lateral sclerosis</b>
<b>(ALS).</b> The management of <i>CHCHD10</i>-related ALS is identical to that of ALS due to other causes, and is outlined in the American Academy of Neurology practice parameter on this topic [<a class="bk_pop" href="#chchd10-dis.REF.miller.1999.1311">Miller et al 1999</a>].</p><ul><li class="half_rhythm"><div>Spasticity can be treated with a spasmolytic such as baclofen or a benzodiazepine.</div></li><li class="half_rhythm"><div>Pseudobulbar affect can be treated with a tricyclic antidepressant or combination of quinidine and dextromethorphan.</div></li><li class="half_rhythm"><div>Sialorrhea is often managed with anticholinergic medications (tricyclic antidepressants, scopolamine, atropine drops) or botulinum toxin injection of the salivary glands.</div></li><li class="half_rhythm"><div>Antidepressants are often required to treat concurrent depression.</div></li><li class="half_rhythm"><div>Riluzole is the only FDA-approved treatment for any type of ALS. Although there are no efficacy data specifically for <i>CHCHD10</i>-related ALS, strong consideration should be given to its use.</div></li></ul><p><b>Frontotemporal dementia (FTD).</b> Treatment follows routine practices.</p><ul><li class="half_rhythm"><div>Sedative or antipsychotic drugs help to reduce extreme restlessness, roaming behavior, delusions, and hallucinations.</div></li><li class="half_rhythm"><div>The extrapyramidal signs are usually unresponsive or only partially responsive to L-dopa treatment.</div></li><li class="half_rhythm"><div>Behavioral changes and the loss of insight and judgment in individuals with FTD often present a considerable burden for partners or other caregivers. Information about the disease and psychological support for partners or other caregivers is essential.</div></li></ul><p><b>Spinal motor neuronopathy.</b> The management of SMAJ is identical to that of adult-onset SMA due to other causes.</p></div><div id="chchd10-dis.Surveillance"><h3>Surveillance</h3><p>The following regular evaluations are indicated to detect manifestations that can occur with time:</p><ul><li class="half_rhythm"><div><b>Neurologic deficits.</b> Neurologic examination including assessment of memory, personality changes</div></li><li class="half_rhythm"><div><b>Psychiatric abnormalities.</b> Assessment for signs including depression and suicidal ideation</div></li><li class="half_rhythm"><div><b>Impaired respiratory function.</b> Monitoring of forced vital capacity (FEV) and other aspects of respiratory function performed at clinic visits to determine the appropriate time to offer noninvasive ventilation</div></li><li class="half_rhythm"><div><b>Sensorineural hearing loss.</b> Audiologic examination including speech discrimination testing</div></li></ul></div><div id="chchd10-dis.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>The following should be noted:</p><ul><li class="half_rhythm"><div>Baclofen used to treat spasticity can sometimes worsen muscle weakness.</div></li><li class="half_rhythm"><div>Some drugs used to treat the behavioral manifestations of FTD may worsen dysarthria, dysphagia, and/or respiratory weakness.</div></li></ul></div><div id="chchd10-dis.Evaluation_of_Relatives_at_R"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#chchd10-dis.Related_Genetic_Counseling_I">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="chchd10-dis.Therapies_Under_Investigatio"><h3>Therapies Under Investigation</h3><p>A clinical trial with the selective serotonin reuptake inhibitor (SSRI) paroxetine showed an increase in cognitive impairment in patients with FTD treated with this drug [<a class="bk_pop" href="#chchd10-dis.REF.deakin.2004.400">Deakin et al 2004</a>]. Conversely, a previous study with another SSRI, trazodone, showed a favorable effect on behavioral disturbances and agitation without cognitive decline [<a class="bk_pop" href="#chchd10-dis.REF.lebert.2004.355">Lebert et al 2004</a>]. Further studies are needed to clarify this issue.</p><p>Several trials with memantine are underway in patients with FTD, as well as a trial with oxytocin and its effect on social cognition.</p><p>Although no current clinical trials are specifically designed to target <i>CHCHD10</i>-related disorders, many are addressed in the broader category of ALS or FTD.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="chchd10-dis.Genetic_Counseling"><h2 id="_chchd10-dis_Genetic_Counseling_">Genetic Counseling</h2><div id="chchd10-dis.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>CHCHD10</i>-related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="chchd10-dis.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Many individuals diagnosed with a <i>CHCHD10</i>-related disorder have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <i>CHCHD10</i>-related disorder may have the disorder as the result of <i>de novo CHCHD10</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, two possible explanations are a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent.</div><ul><li class="half_rhythm"><div>The proportion of <i>CHCHD10</i>-related disorders caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is unknown.</div></li><li class="half_rhythm"><div>Although no instances of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> have been reported, it remains a possibility.</div></li></ul></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include thorough clinical examination and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the <i>CHCHD10</i> pathogenic variant identified in the proband.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with a <i>CHCHD10</i>-related disorder may appear to be negative because of failure by health care professionals to recognize the disorder in family members and/or milder phenotypic presentation, early death of the parent before the onset of symptoms, or late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate clinical and molecular testing has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs of inheriting the <i>CHCHD10</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is 50%.</div></li><li class="half_rhythm"><div>If the <i>CHCHD10</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with a <i>CHCHD10</i>-related disorder has a 50% chance of inheriting the <i>CHCHD10</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has a <i>CHCHD10</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="chchd10-dis.Related_Genetic_Counseling_I"><h3>Related Genetic Counseling Issues</h3><p><b>Testing of at-risk asymptomatic adult relatives</b> of individuals with a <i>CHCHD10</i>-related disorder is possible after <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has identified the specific <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family. Such testing should be performed in the context of formal <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a>. This testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. Testing of asymptomatic at-risk individuals with nonspecific or equivocal symptoms is predictive testing, not diagnostic testing.</p><p><b>Testing of asymptomatic individuals younger than age 18 years</b> who are at risk for adult-onset disorders for which no treatment exists is not considered appropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</p><p>Testing is appropriate to consider in symptomatic individuals in a family with an established diagnosis of a <i>CHCHD10</i>-related disorder regardless of age.</p><p>For more information, see also the National Society of Genetic Counselors <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">position statement</a> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">policy statement</a>: ethical and policy issues in genetic testing and screening of children.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband, the pathogenic variant is likely <i>de novo</i>. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy. Similarly, decisions about testing to determine the genetic status of at-risk asymptomatic family members are best made before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="chchd10-dis.Prenatal_Testing_and_Preimpl"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>CHCHD10</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk for a <i>CHCHD10</i>-related disorder and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="chchd10-dis.Resources"><h2 id="_chchd10-dis_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><p>No specific resources for <i>CHCHD10</i>-Related Disorders have been identified by <i>GeneReviews</i> staff.</p></div><div id="chchd10-dis.Molecular_Genetics"><h2 id="_chchd10-dis_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="chchd10-dis.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>CHCHD10-Related Disorders: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK304142/table/chchd10-dis.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chchd10-dis.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_chchd10-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_chchd10-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_chchd10-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_chchd10-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_chchd10-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_chchd10-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/400916" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CHCHD10</i></a></td><td headers="hd_b_chchd10-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=400916" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">22q11<wbr style="display:inline-block"></wbr>​.23</a></td><td headers="hd_b_chchd10-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8WYQ3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial</a></td><td headers="hd_b_chchd10-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CHCHD10" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHCHD10</a></td><td headers="hd_b_chchd10-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CHCHD10[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHCHD10</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="chchd10-dis.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="chchd10-dis.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for CHCHD10-Related Disorders (<a href="/omim/615048,615903,615911,616209" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK304142/table/chchd10-dis.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chchd10-dis.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615048" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615048</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615903" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615903</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 10; CHCHD10</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615911" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615911</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616209" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616209</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>CHCHD10</i> consists of four exons. Exons 1 and 2 are particularly GC-rich. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK304142/#chchd10-dis.molgen.TA">Table A</a>, <b>Gene</b>.</p><p>Alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> results in multiple transcripts. The longer transcript variant <a href="/nuccore/NM_001301339.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001301339.1</a> produces an isoform composed of 149 amino acids (<a href="/protein/NP_001288268.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001288268.1</a>) and the transcript variant <a href="/nuccore/NM_213720.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_213720.2</a> produces a shorter isoform (<a href="/protein/NP_998885.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_998885.1</a>) which is composed of 142 amino acids. See also the UniProtKB/Swiss-Prot reference <a href="http://www.uniprot.org/entry/Q8WYQ3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Q8WYQ3</a></p><p><i>CHCHD10</i> was previously referred to as <i>C22orf16</i>.</p><p><b>Pathogenic variants.</b>
<i>CHCHD10</i> has only recently been associated with disease. To date all identified <i>CHCHD10</i> pathogenic variants are located in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2. To date no <i>CHCHD10</i> deletions/duplications have been reported.</p><p>The pathogenicity of many of these variants has not been proven by functional studies. In addition, <i>CHCHD10</i> is often poorly covered in <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> data and, therefore, even quite common variants may be absent from databases, complicating the interpretation of variants within this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p><p>The <i>CHCHD10</i> variant <a class="figpopup" href="/books/NBK304142/table/chchd10-dis.T.chchd10_variants_discussed/?report=objectonly" target="object" rid-figpopup="figchchd10disTchchd10variantsdiscussed" rid-ob="figobchchd10disTchchd10variantsdiscussed">p.Arg15Leu</a> was identified in six of 213 families with ALS [<a class="bk_pop" href="#chchd10-dis.REF.johnson.2014.e311">Johnson et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.m_ller.2014.e309">M&#x000fc;ller et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.kurzwelly.2015.e376">Kurzwelly et al 2015</a>]. <a class="bk_pop" href="#chchd10-dis.REF.zhang.2015.e380">Zhang et al [2015]</a> reported this variant in an individual with <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> ALS (i.e., a single occurrence in a family).</p><p>The p.Arg15Ser variant was found in <a class="def" href="/books/n/gene/glossary/def-item/cis/"><i>cis</i></a> configuration with p.Gly58Ser in ten individuals in a Puerto Rican family with mitochondrial myopathy without mtDNA deletions [<a class="bk_pop" href="#chchd10-dis.REF.ajrouddriss.2015.1">Ajroud-Driss et al 2015</a>].</p><p>The <a class="figpopup" href="/books/NBK304142/table/chchd10-dis.T.chchd10_variants_discussed/?report=objectonly" target="object" rid-figpopup="figchchd10disTchchd10variantsdiscussed" rid-ob="figobchchd10disTchchd10variantsdiscussed">p.[Arg15Ser;Gly58Arg]</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was identified in a pure early-onset mitochondrial myopathy [<a class="bk_pop" href="#chchd10-dis.REF.ajrouddriss.2015.1">Ajroud-Driss et al 2015</a>]. Biochemical analysis showed respiratory chain dysfunction in muscle biopsies from <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. The expression of the p.Gly58Arg, but not p.Arg15Ser, pathogenic variant in transfected cultured cells induced mitochondrial fragmentation. Because the variant is adjacent to p.Ser59Leu, this part of the protein is hypothesized to likely be of importance to mitochondrial function [<a class="bk_pop" href="#chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</a>].</p><p>The p.Ser59Leu <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was first identified in a large family in which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals presented with atypical FTD/ALS and mitochondrial myopathy [<a class="bk_pop" href="#chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</a>]. In all affected individuals, muscle biopsy showed ragged-red and COX-negative fibers with combined respiratory chain deficiency and abnormal assembly of complex V. The multiple mitochondrial DNA deletions found in skeletal muscle revealed a mitochondrial DNA instability disorder. Fibroblasts from affected individuals showed respiratory chain deficiency, mitochondrial ultrastructural alterations, and fragmentation of the mitochondrial network [<a class="bk_pop" href="#chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</a>]. Overexpression of the <i>CHCHD10</i> pathogenic variant in HeLa cells led to fragmentation of the mitochondrial network and major ultrastructural abnormalities including loss, disorganization, and dilatation of cristae. As a polar residue of the hydrophobic helix, amino acid Ser59 may intervene in hydrogen bonds to stabilize CHCHD10 interaction with another protein.</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> <a class="figpopup" href="/books/NBK304142/table/chchd10-dis.T.chchd10_variants_discussed/?report=objectonly" target="object" rid-figpopup="figchchd10disTchchd10variantsdiscussed" rid-ob="figobchchd10disTchchd10variantsdiscussed">p.Gly66Val</a> was identified in 55 individuals from 17 Finnish families [<a class="bk_pop" href="#chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</a>]. The variant p.Gly66Val is a cause of late-onset spinal motor neuronopathy (SMAJ). Because valine is larger in size than glycine, it has been suggested that the bulkier valine molecule could affect the overall structure of the hydrophobic helix [<a class="bk_pop" href="#chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</a>].</p><p><a class="bk_pop" href="#chchd10-dis.REF.zhang.2015.e380">Zhang et al [2015]</a> described the p.Pro80Leu variant in an individual with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> ALS and in an individual with <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> ALS (i.e., a single occurrence in a family). <a class="bk_pop" href="#chchd10-dis.REF.ronchi.2015.e372">Ronchi et al [2015]</a> described the same variant in two individuals with simplex ALS. Respiratory chain analysis performed on skeletal muscle of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual with early-onset simplex ALS with the <i>CHCHD10</i> p.Pro80Leu variant revealed combined respiratory chain deficiency and a severe mitochondrial myopathy; further functional analysis would be helpful for validation of its pathogenicity [<a class="bk_pop" href="#chchd10-dis.REF.ronchi.2015.e372">Ronchi et al 2015</a>]. This variant has also been observed in the general population (<a href="http://exac.broadinstitute.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">exac.broadinstitute.org</a>).</p><p>Testing of 115 unrelated individuals with FTD-ALS identified two unrelated individuals with a p.Pro34Ser variant [<a class="bk_pop" href="#chchd10-dis.REF.chaussenot.2014.2884.e1">Chaussenot et al 2014</a>]. <a class="bk_pop" href="#chchd10-dis.REF.ronchi.2015.e372">Ronchi et al [2015]</a> also identified the same variant in an individual with ALS (of 224 tested). Although the p.Pro34Ser is present in the normal population, it does not segregate with the disease [<a class="bk_pop" href="#chchd10-dis.REF.dobsonstone.2015.e385">Dobson-Stone et al 2015</a>, <a class="bk_pop" href="#chchd10-dis.REF.zhang.2015.e380">Zhang et al 2015</a>]; however, functional studies favor its pathogenicity [personal data, manuscript submitted].</p><div id="chchd10-dis.T.chchd10_variants_discussed" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>CHCHD10</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK304142/table/chchd10-dis.T.chchd10_variants_discussed/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chchd10-dis.T.chchd10_variants_discussed_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.44G&#x0003e;T</td><td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg15Leu</td><td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_3" rowspan="8" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_001301339.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001301339<wbr style="display:inline-block"></wbr>​.1</a>&#x000a0;<sup>1</sup><br /><a href="/protein/NP_001288268.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001288268<wbr style="display:inline-block"></wbr>​.1</a>&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.67C&#x0003e;A</td><td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro23Thr</td></tr><tr><td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.100C&#x0003e;T</td><td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro34Ser</td></tr><tr><td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.104C&#x0003e;A</td><td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala35Asp</td></tr><tr><td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.176C&#x0003e;T</td><td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser59Leu</td></tr><tr><td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.197G&#x0003e;T</td><td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly66Val</td></tr><tr><td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.239C&#x0003e;T</td><td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro80Leu</td></tr><tr><td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.[43C&#x0003e;G;172G&#x0003e;C]</td><td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.[Arg15Ser;Gly58Arg]</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="chchd10-dis.TF.4.1"><p class="no_margin">Nucleotide and amino acid changes for pathogenic variants are numbered the same for alternate reference sequences <a href="/nuccore/NM_213720.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_213720<wbr style="display:inline-block"></wbr>​.2</a>, <a href="/protein/NP_998885.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_998885<wbr style="display:inline-block"></wbr>​.1</a>.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> CHCHD10, a small mitochondrial protein encoded by the nuclear gene <i>CHCHD10</i>, belongs to a family of mitochondrial proteins characterized by conserved CXnX motifs, some of which are involved in cristae integrity and mitochondrial fusion [<a class="bk_pop" href="#chchd10-dis.REF.darshi.2011.2918">Darshi et al 2011</a>, <a class="bk_pop" href="#chchd10-dis.REF.an.2012.7411">An et al 2012</a>].</p><p>CHCHD10 is ubiquitous and highly expressed in organs with high mitochondrial content such as the heart and liver. It is located in the intermembrane space of mitochondria, enriched at cristae junctions and plays a role in the maintenance of mitochondrial network [<a class="bk_pop" href="#chchd10-dis.REF.ajrouddriss.2015.1">Ajroud-Driss et al 2015</a>], the morphology of mitochondrial cristae, and the stability of mitochondrial DNA [<a class="bk_pop" href="#chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</a>]. CHCHD10 has also been shown to be involved in oxidative phosphorylation, and it possibly takes part in the function of complex IV of the respiratory chain [<a class="bk_pop" href="#chchd10-dis.REF.martherus.2010.203">Martherus et al 2010</a>].</p><p>CHCHD10 contains a conserved mitochondrial targeting signal, is highly co-expressed with other mitochondrial genes, and is transcriptionally activated during mitochondrial biogenesis [<a class="bk_pop" href="#chchd10-dis.REF.ajrouddriss.2015.1">Ajroud-Driss et al 2015</a>]. The predicted model of CHCHD10 consists of a non-structured N-terminal region, a highly hydrophobic helix (amino acids 43-68), and the CHCH <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> near the C-terminal region. The hydrophobic helix may function as an interface of interaction with other proteins and the four cysteine residues (102, 112, 122, 132) of the CHCH domain are involved in two disulfide bonds [<a class="bk_pop" href="#chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</a>, <a class="bk_pop" href="#chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Based on current knowledge the ways by which <i>CHCHD10</i> pathogenic variants could cause disease are by disorganizing mitochondrial cristae, impairing the mitochondrial network, and inducing deficiency in oxidative phosphorylation. Further functional analyses are required for understanding how <i>CHCHD10</i> pathogenic variants promote motor neuron disease (MND). Although there is no conclusive evidence to date, it appears that <i>CHCHD10</i> pathogenic variants are likely <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a>.</p></div><div id="chchd10-dis.References"><h2 id="_chchd10-dis_References_">References</h2><div id="chchd10-dis.Published_Guidelines__Consen"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF1">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2013. Accessed 11-7-18. [<a href="/pubmed/23428972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23428972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF2">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2017. Accessed 11-7-18.</div></li></ul></div><div id="chchd10-dis.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.ajrouddriss.2015.1">Ajroud-Driss S, Fecto F, Ajroud K, Lalani I, Calvo SE, Mootha VK, Deng HX, Siddique N, Tahmoush AJ, Heiman-Patterson TD, Siddique T. Mutation in the novel nuclear-encoded mitochondrial protein CHCHD10 in a family with autosomal dominant mitochondrial myopathy. <span><span class="ref-journal">Neurogenetics. </span>2015;<span class="ref-vol">16</span>:1–9.</span> [<a href="/pmc/articles/PMC4796476/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4796476</span></a>] [<a href="/pubmed/25193783" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25193783</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.an.2012.7411">An J, Shi J, He Q, Lui K, Liu Y, Huang Y, Sheikh MS. CHM1/CHCHD6, a novel mitochondrial protein linked to regulation of mitofilin and mitochondrial cristae morphology. <span><span class="ref-journal">J Biol Chem. </span>2012;<span class="ref-vol">287</span>:7411–26.</span> [<a href="/pmc/articles/PMC3293568/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3293568</span></a>] [<a href="/pubmed/22228767" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22228767</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.bannwarth.2014.2329">Bannwarth S, Ait-El-Mkadem S, Chaussenot A, Genin EC, Lacas-Gervais S, Fragaki K, Berg-Alonso L, Kageyama Y, Serre V, Moore DG, Verschueren A, Rouzier C, Le Ber I, Aug&#x000e9; G, Cochaud C, Lespinasse F, N'Guyen K, de Septenville A, Brice A, Yu-Wai-Man P, Sesaki H, Pouget J, Paquis-Flucklinger V. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. <span><span class="ref-journal">Brain. </span>2014;<span class="ref-vol">137</span>:2329–45.</span> [<a href="/pmc/articles/PMC4107737/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4107737</span></a>] [<a href="/pubmed/24934289" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24934289</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.bannwarth.2015.e377">Bannwarth S, Ait-El-Mkadem S, Chaussenot A, Genin EC, Lacas-Gervais S, Fragaki K, Berg-Alonso L, Kageyama Y, Serre V, Moore D, Verschueren A, Rouzier C, Le Ber I, Aug&#x000e9; G, Cochaud C, Lespinasse F, N'Guyen K, de Septenville A, Brice A, Yu-Wai-Man P, Sesaki H, Pouget J, Paquis-Flucklinger V. Reply: a distinct clinical phenotype in a German kindred with motor neuron disease carryig a CHCHD10 mutation. <span><span class="ref-journal">Brain. </span>2015;<span class="ref-vol">138</span>:e377.</span> [<a href="/pmc/articles/PMC4547050/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4547050</span></a>] [<a href="/pubmed/25681413" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25681413</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.bird.1999.741">Bird TD, Nochlin D, Poorkaj P, Cherrier M, Kaye J, Payami H, Peskind E, Lampe TH, Nemens E, Boyer PJ, Schellenberg GD. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L). <span><span class="ref-journal">Brain. </span>1999;<span class="ref-vol">122</span>:741–56.</span> [<a href="/pubmed/10219785" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10219785</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.brooks.2000.293">Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases; El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. <span><span class="ref-journal">Amyotroph Lateral Scler Other Motor Neuron Disord. </span>2000;<span class="ref-vol">1</span>:293–9.</span> [<a href="/pubmed/11464847" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11464847</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.chaussenot.2014.2884.e1">Chaussenot A, Le Ber I, Ait-El-Mkadem S, Camuzat A, de Septenville A, Bannwarth S, Genin EC, Serre V, Aug&#x000e9; G. French research network on FTD and FTD-ALS, Brice A, Pouget J, Paquis-Flucklinger V. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients. <span><span class="ref-journal">Neurobiol Aging. </span>2014;<span class="ref-vol">35</span>:2884.e1–2884.e4.</span> [<a href="/pubmed/25155093" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25155093</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.darshi.2011.2918">Darshi M, Mendiola VL, Mackey MR, Murphy AN, Koller A, Perkins GA, Ellisman MH, Taylor SS. ChChd3, an inner mitochondrial membrane protein, is essential for maintening crista integrity and mitochondrial function. <span><span class="ref-journal">J Biol Chem. </span>2011;<span class="ref-vol">286</span>:2918–32.</span> [<a href="/pmc/articles/PMC3024787/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3024787</span></a>] [<a href="/pubmed/21081504" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21081504</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.deakin.2004.400">Deakin JB, Rahman S, Nestor PJ, Hodges JR, Sahakian BJ. Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial. <span><span class="ref-journal">Psychopharmacology (Berl). </span>2004;<span class="ref-vol">172</span>:400–8.</span> [<a href="/pubmed/14666399" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14666399</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.dobsonstone.2015.e385">Dobson-Stone C, Shaw AD, Hallupp M, Bartley L, McCann H, Brooks WS, Loy CT, Schofield PR, Mather KA, Kochan NA, Sachdev PS, Halliday GM, Piguet O, Hodges JR, Kwok JB. Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis? <span><span class="ref-journal">Brain. </span>2015;<span class="ref-vol">138</span>:e385.</span> [<a href="/pubmed/25953780" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25953780</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.foster.2007.2616">Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, Barbas NR, DeCarli CS, Turner RS, Koeppe RA, Higdon R, Minoshima S. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. <span><span class="ref-journal">Brain. </span>2007;<span class="ref-vol">130</span>:2616–35.</span> [<a href="/pubmed/17704526" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17704526</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.foster.1997.706">Foster NL, Wilhelmsen K, Sima AA, Jones MZ, D'Amato CJ, Gilman S. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants. <span><span class="ref-journal">Ann Neurol. </span>1997;<span class="ref-vol">41</span>:706–15.</span> [<a href="/pubmed/9189031" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9189031</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.gitcho.2008.535">Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, Hatanpaa KJ, White CL, Bigio EH, Caselli R, Baker M, Al-Lozi MT, Morris JC, Pestronk A, Rademakers R, Goate AM, Cairns NJ. TDP-43 A315T mutation in familial motor neuron disease. <span><span class="ref-journal">Ann Neurol. </span>2008;<span class="ref-vol">63</span>:535–8.</span> [<a href="/pmc/articles/PMC2747362/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2747362</span></a>] [<a href="/pubmed/18288693" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18288693</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.gornotempini.2011.1006">Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam MM, Grossman M. Classification of primary progressive aphasia and its variants. <span><span class="ref-journal">Neurology. </span>2011;<span class="ref-vol">76</span>:1006–14.</span> [<a href="/pmc/articles/PMC3059138/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3059138</span></a>] [<a href="/pubmed/21325651" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21325651</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.johnson.2014.e311">Johnson JO, Glynn SM, Gibbs JR, Nalls MA, Sabatelli M, Restagno G, Drory VE, Chi&#x000f2; A, Rogaeva E, Traynor BJ. Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis. <span><span class="ref-journal">Brain. </span>2014;<span class="ref-vol">137</span>:e311.</span> [<a href="/pmc/articles/PMC4240285/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4240285</span></a>] [<a href="/pubmed/25261972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25261972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.k_hnlein.2008.1185">K&#x000fc;hnlein P, Sperfeld AD, Vanmassenhove B, Van Deerlin V, Lee VM, Trojanowski JQ, Kretzschmar HA, Ludolph AC, Neumann M. Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations. <span><span class="ref-journal">Arch Neurol. </span>2008;<span class="ref-vol">65</span>:1185–9.</span> [<a href="/pmc/articles/PMC2742976/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2742976</span></a>] [<a href="/pubmed/18779421" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18779421</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.kurzwelly.2015.e376">Kurzwelly D, Kr&#x000fc;ger S, Biskup S, Heneka MT. A distinct clinical phenotype in a German kindred with motor neuron disease carrying a CHCHD10 mutation. <span><span class="ref-journal">Brain. </span>2015;<span class="ref-vol">138</span>:e376.</span> [<a href="/pubmed/25681414" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25681414</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.lebert.2004.355">Lebert F, Stekke W, Hasenbroekx C, Pasquier F. Frontotemporal dementia: a randomised, controlled trial with trazodone. <span><span class="ref-journal">Dement Geriatr Cogn Disord. </span>2004;<span class="ref-vol">17</span>:355–9.</span> [<a href="/pubmed/15178953" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15178953</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.martherus.2010.203">Martherus RS, Sluiter W, Timmer ED, VanHerle SJ, Smeets HJ, Ayoubi TA. Functional annotation of heart enriched mitochondrial genes GBAS and CHCHD10 through guilt by association. <span><span class="ref-journal">Biochem Biophys Res Com. </span>2010;<span class="ref-vol">402</span>:203–8.</span> [<a href="/pubmed/20888800" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20888800</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.miller.1999.1311">Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, Borasio GD, Bradley WG, Bromberg MB, Brooks BR, Kasarskis EJ, Munsat TL, Oppenheimer EA. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. <span><span class="ref-journal">Neurology. </span>1999;<span class="ref-vol">52</span>:1311–23.</span> [<a href="/pubmed/10227612" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10227612</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.mioshi.2010.1591">Mioshi E, Hsieh S, Savage S, Hornberger M, Hodges JR. Clinical staging and disease progression in frontotemporal dementia. <span><span class="ref-journal">Neurology. </span>2010;<span class="ref-vol">74</span>:1591–7.</span> [<a href="/pubmed/20479357" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20479357</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.m_ller.2014.e309">M&#x000fc;ller K, Andersen PM, H&#x000fc;bers A, Marroquin N, Volk AE, Danzer KM, Meitinger T, Ludolph AC, Strom TM, Weishaupt JH. Two novel mutations in conserved codons indicate that CHCHD10 is a gene associated with motor neuron disease. <span><span class="ref-journal">Brain. </span>2014;<span class="ref-vol">137</span>:e309.</span> [<a href="/pubmed/25113787" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25113787</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; S, Jokela M, Bouquin H, Saukkonen AM, Toivanen J, Udd B. Late onset spinal motor neuronopathy is caused by mutation in CHCHD10. <span><span class="ref-journal">Ann Neurol. </span>2015;<span class="ref-vol">77</span>:163–72.</span> [<a href="/pubmed/25428574" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25428574</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.renton.2011.257">Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Janel OJ, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelar H, Blake D, Young K, Halliwell N, Bennoin Callister J, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita VM, Kaivorrinne AL, Holtta-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chio A, Restagno G, Borghero G, Sabatelli M., The ITALSGEN Consortium.  Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ. A hexanucleotide repeat expansion in C9ORF72 Is the cause of chromosome 9p21-linked ALS-FTD. <span><span class="ref-journal">Neuron. </span>2011;<span class="ref-vol">72</span>:257–68.</span> [<a href="/pmc/articles/PMC3200438/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3200438</span></a>] [<a href="/pubmed/21944779" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21944779</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.ronchi.2015.e372">Ronchi D, Riboldi G, Del Bo R, Ticozzi N, Scarlato M, Galimberti D, Corti S, Silani V, Bresolin N, Comi GP. CHCHD10 mutations in Italian patients with sporadic amyotrophic lateral sclerosis. <span><span class="ref-journal">Brain. </span>2015;<span class="ref-vol">138</span>:e372.</span> [<a href="/pubmed/25576308" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25576308</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.schmitzh_bsch.2006.1717">Schmitz-H&#x000fc;bsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, Giunti P, Globas C, Infante J, Kang JS, Kremer B, Mariotti C, Melegh B, Pandolfo M, Rakowicz M, Ribai P, Rola R, Sch&#x000f6;ls L, Szymanski S, van de Warrenburg BP, D&#x000fc;rr A, Klockgether T, Fancellu R. Scale for the assessment and rating of ataxia: development of a new clinical scale. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">66</span>:1717–20.</span> [<a href="/pubmed/16769946" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16769946</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.traynor.2000.109">Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Amyotrophic lateral sclerosis mimic syndromes: a population-based study. <span><span class="ref-journal">Arch Neurol. </span>2000;<span class="ref-vol">57</span>:109–13.</span> [<a href="/pubmed/10634456" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10634456</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.van_swieten.1999.617">van Swieten JC, Stevens M, Rosso SM, Rizzu P, Joosse M, de Koning I, Kamphorst W, Ravid R, Spillantini MG. Phenotypic variation in hereditary frontotemporal dementia with tau mutations. <span><span class="ref-journal">Ann Neurol. </span>1999;<span class="ref-vol">46</span>:617–26.</span> [<a href="/pubmed/10514099" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10514099</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.wszolek.1992.312">Wszolek ZK, Pfeiffer RF, Bhatt MH, Schelper RL, Cordes M, Snow BJ, Rodnitzky RL, Wolters EC, Arwert F, Calne DB. Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration. <span><span class="ref-journal">Ann Neurol. </span>1992;<span class="ref-vol">32</span>:312–20.</span> [<a href="/pubmed/1416801" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1416801</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chchd10-dis.REF.zhang.2015.e380">Zhang M, Xi Z, Zinman L, Bruni AC, Maletta RG, Curcio SA, Rainero I, Rubino E, Pinessi L, Nacmias B, Sorbi S, Galimberti D, Lang AE, Fox S, Surace EI, Ghani M, Guo J, Sato C, Moreno D, Liang Y, Keith J, Traynor BJ, St George-Hyslop P, Rogaeva E. Mutation analysis of CHCHD10 in different neurodegenerative diseases. <span><span class="ref-journal">Brain. </span>2015;<span class="ref-vol">138</span>:e380.</span> [<a href="/pmc/articles/PMC4547051/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4547051</span></a>] [<a href="/pubmed/25833818" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25833818</span></a>]</div></li></ul></div></div><div id="chchd10-dis.Chapter_Notes"><h2 id="_chchd10-dis_Chapter_Notes_">Chapter Notes</h2><div id="chchd10-dis.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>1 July 2015 (me) Review posted live</div></li><li class="half_rhythm"><div>20 January 2015 (saem) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK304142</span><span class="label">PMID: <a href="/pubmed/26131548" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">26131548</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/charge/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/chd2-dis/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK304142&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK304142/?report=reader">PubReader</a></li><li><a href="/books/NBK304142/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK304142" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK304142" style="display:none" title="Cite this Page"><div class="bk_tt">Ait-El-Mkadem S, Chaussenot A, Bannwarth S, et al. CHCHD10-Related Disorders. 2015 Jul 1. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK304142/pdf/Bookshelf_NBK304142.pdf">PDF version of this page</a> (477K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#chchd10-dis.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#chchd10-dis.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#chchd10-dis.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#chchd10-dis.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#chchd10-dis.Genetically_Related_Allelic" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#chchd10-dis.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#chchd10-dis.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#chchd10-dis.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#chchd10-dis.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#chchd10-dis.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#chchd10-dis.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#chchd10-dis.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=400916[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CHCHD10</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4083556" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4083556" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4083556" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4083556" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301294" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brashear A, Sweadner KJ, Cook JF, Swoboda KJ, Ozelius L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301761" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TARDBP</i>-Related Amyotrophic Lateral Sclerosis</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TARDBP</i>-Related Amyotrophic Lateral Sclerosis<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Harms MM, Miller TM, Baloh RH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301545" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">GRN</i>-Related Frontotemporal Dementia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">GRN</i>-Related Frontotemporal Dementia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hsiung GYR, Feldman HH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31294938" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 38</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 38<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brusco A, Di Gregorio E, Borroni B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301649" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Inclusion Body Myopathy with Paget Disease of Bone and/or Frontotemporal Dementia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Inclusion Body Myopathy with Paget Disease of Bone and/or Frontotemporal Dementia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kimonis V. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=26131548" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=26131548" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040f9d75f66d18aabeddbc">CHCHD10-Related Disorders - GeneReviews®</a><div class="ralinkpop offscreen_noflow">CHCHD10-Related Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:40:45-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8C4422E03F2E51000000000AA303C4&amp;ncbi_session=CE8C4422E040F9D1_2723SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK304142%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK304142&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK304142/&amp;ncbi_pagename=CHCHD10-Related Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C4422E040F9D1_2723SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>